Yunling Lin Xun Yuan Lianglong Chen
10.3389/fcvm.2022.955527
Front Cardiovasc Med
2022 Oct 6;9:955527.
pd-1 cardio-oncology immune-related adverse events lung adenocarcinoma myocarditis sintilimab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36277753/
Case Reports
PMC9582520
36277753
Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report
2022